Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
04 nov. 2024 16h05 HE
|
Longeveron
Longveron will report third quarter 2024 financial results and provide a business update on Tuesday, November 12th after the U.S. financial markets close.
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
29 oct. 2024 10h00 HE
|
Longeveron
Longeveron presents clinical data for stem cell therapy in Alzheimer's disease. Findings offer potential mechanistic and clinical insights.
RMS Sponsors the 5th Summit on Stem Cell Derived Islets
29 oct. 2024 09h00 HE
|
Regenerative Medical Solutions
Boston, MA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Regenerative Medical Solutions (RMS) is sponsoring the 5th Summit on Stem Cell Derived Islets, which will be held on October 28-29 at the Joseph B....
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
27 oct. 2024 15h10 HE
|
Longeveron
Longeveron reports positive long-term transplant-free survival (100% survival) data from a multi-year study in Hypoplastic Left Heart Syndrome (HLHS)
Amyotrophic Lateral Sclerosis Treatment Market to hit USD 1.1 billion by 2032, says Global Market Insights Inc.
24 oct. 2024 05h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Amyotrophic Lateral Sclerosis (ALS) Treatment Market size was valued at USD 713.3 million in 2023 and is expected to grow at a CAGR of 5.5%...
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
14 oct. 2024 09h05 HE
|
Longeveron
Longeveron Lomecel-B data in Alzheimer's disease selected for late breaking poster presentation at Clinical Trials on Alzheimer’s Disease Conf (CTAD24).
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day
07 oct. 2024 09h05 HE
|
Longeveron
Wa’el Hashad, Chief Executive Officer of Longeveron, will participate in a Fireside Chat at the UBS Virtual Organ Restoration and Cell Therapy Day Oct 15th
India Cord Blood Banking Market, Competition, Forecast and Opportunities, 2020-2023 & 2024-2030
26 août 2024 10h33 HE
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "India Cord Blood Banking Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
Aplastic Anemia Market Size & Share to Surpass USD 10.8 Billion by 2034, at a CAGR 4.3% - Transparency Market Research, Inc.
26 août 2024 05h57 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The global aplastic anemia market (再生不良性貧血市場) was projected to attain US$ 6.7 billion in...
Regenerative Dentistry Market Anticipated to Achieve US$ 5.3 Billion Valuation by 2034, Growing at 5.4% CAGR: TMR Report
17 juil. 2024 12h43 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc. , July 17, 2024 (GLOBE NEWSWIRE) -- The global regenerative dentistry market (재생 치과 시장) is estimated to thrive at a CAGR of...